Landscapes / Targets
CDK4/6
13 drugs act on CDK4/6, in 54 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs13
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Kinase inhibitor |
Pfizer · Public PFE |
Approved | 30 Dec 2026Phase 3 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | 30 Dec 2026 · Phase 3 trial completes | ||||
| Also tested for | Breast Cancer, Locally Advanced or Metastatic ER+ HER2- Breast Cancer and 3 more | ||||
| Open drug page | |||||
Kinase inhibitor |
Approved | 1 Feb 2027Phase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 1 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Early Breast Cancer and 7 more | ||||
| Open drug page | |||||
Kinase inhibitor |
Eli Lilly · Public LLY |
Approved | Feb 2027Phase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Breast Cancer, Breast Neoplasms and 29 more | ||||
| Open drug page | |||||
Cyclin-dependent kinase inhibitor |
Approved | 15 Jul 2027Phase 3 trial completes | |||
| How it works | Blocks CDK enzymes that let cells divide | ||||
| Next date | 15 Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Extensive-stage Small-cell Lung Cancer, Limited Stage Small Cell Lung Cancer and 1 more | ||||
| Open drug page | |||||
Cyclin-dependent kinase inhibitor |
Genor Biopharma · Public 6998.HK |
Approved in China | — | ||
| How it works | Blocks CDK enzymes that let cells divide | ||||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 2/3 | 1 Dec 2026soonPhase 2/3 trial completes | |||
| Next date | 1 Dec 2026 · Phase 2/3 trial completes | ||||
| Also tested for | Locally Advanced or Metastatic Breast Cancer, Breast Cancer Brain Metastases and 1 more | ||||
| Open drug page | |||||
Cyclin-dependent kinase inhibitor |
Pfizer · Public PFE |
Phase 3 | 2 Jan 2029Phase 3 trial completes | ||
| How it works | Blocks CDK enzymes that let cells divide | ||||
| Next date | 2 Jan 2029 · Phase 3 trial completes | ||||
| Also tested for | Advanced Breast Cancer, Advanced or Metastatic Breast Cancer and 13 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Advanced Breast Cancer | ||||
| Open drug page | |||||
Cyclin-dependent kinase inhibitor |
Phase 1/2 | 31 Dec 2026Phase 1/2 trial completes | |||
| How it works | Blocks CDK enzymes that let cells divide | ||||
| Next date | 31 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Glioma | ||||
| Open drug page | |||||
Mocaciclibnot checked |
Cyclin-dependent kinase inhibitor |
Phase 1/2 | 31 Mar 2029Phase 1/2 trial completes | ||
| How it works | Blocks CDK enzymes that let cells divide | ||||
| Next date | 31 Mar 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Cancer, Metastatic Cancer | ||||
| Open drug page | |||||
— |
Tasly · Public 600535.SS |
Phase 1 | 31 Dec 2026Phase 1 trial completes | ||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Metastatic Castration-Resistant Prostate Cancer Patients | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2027Phase 1 trial completes | |||
| Next date | 30 Sep 2027 · Phase 1 trial completes | ||||
| Also tested for | Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 13 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026